Course:
CME Credits: 0.00
Released: 2025-01-22
Bridging Community: Collaborative Efforts in Early Detection and Intervention for Alzheimer’s Disease is an innovative educational program tailored for family medicine physicians, as well as primary care practitioners—including OB/GYNs, NPs, PAs—alongside general neurologists, psychiatrists, and other members of the interprofessional healthcare team. This program empowers clinicians who play a pivotal role in identifying and managing patients at risk of early Alzheimer’s disease (AD) and cognitive impairment. Participants will gain actionable insights from expert faculty, who will explore: Through case-based discussions and sharing multidisciplinary perspectives, learners will deepen their understanding of clinical challenges and refine their approach to AD patient care. Join us in bridging the gap between early Alzheimer's disease detection and intervention for a brighter future in brain health. *First FDA approved (May 2025, after recording of this activity) in vitro diagnostic device to test blood (pTau217/ß-Amyloid 1-42 plasma ratio) to aid in diagnosing early symptomatic AD in patients ? 55 years.
Upon completion of this CE activity, participants should be better able to:
View Full Course